Ledger.Open graph →
SEC Form D · Amendment · filed March 26, 2019

Beam Therapeutics Inc

Offering
$83.6M
Sold
$83.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Carole Ho · CAMBRIDGE, MADirectorJohn Evans · CAMBRIDGE, MAExec · DirectorMark Fishman · CAMBRIDGE, MADirectorMichael Yi · CAMBRIDGE, MADirectorRobert Nelsen · CAMBRIDGE, MADirectorKristina Burow · CAMBRIDGE, MADirectorStephen Knight · CAMBRIDGE, MADirectorRobert Archer · VANCOUVER, British Columbia, CanadaDirectorChristopher J. Finley · Ridgefield, WADirectorAnn Marie A. Foley · SAN FRANCISCO, CADirectorAlan Bird · Miami, FLDirectorDeborah Robinson · Miami, FLDirectorKelly M. Pladson · VANCOUVER, British Columbia, CanadaExec · DirectorAnn Marie A. Foley · San Francisco, CADirectorAlberto J. Toro · SAN JUAN, PR, Puerto RicoDirectorEduardo M. Inclan · San Juan, Puerto RicoDirectorRandal V. Roat · Palmetto, FLDirectorVanessa M. Zampiga · Dallas, TXExec · DirectorA. M. Muscolino · Dallas, TXDirectorRobert Keith Iii · Franklin, INDirectorDerek Pew · Franklin, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗